Outcome Analysis of the Oxford Partial Knee Arthroplasty

Knee Arthroplasty Clinical Trial

Official title:

Outcome Analysis of the Oxford Partial Knee Arthroplasty

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00759616
• Other study ID #: BMET CA 03
• Status: Completed
• Phase: N/A
• First received: September 24, 2008
• Last updated: June 15, 2017
• Start date: April 2003
• Est. completion date: June 2009

Study information

• Verified date: June 2017
• Source: Zimmer Biomet
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Prospectively monitor the patients receiving the Oxford Partial knee arthroplasty

Description:

Utilization of systematic outcome measurements and specific designated time frames to monitor patient satisfactions will assist in analysing this type of prosthesis and the post operative period. Data collected will be added to the compiled information from previous studies in relation to the Oxford knee.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 156
• Est. completion date: June 2009
• Est. primary completion date: June 2009
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Patient Suitable for Knee Replacement

Exclusion Criteria:

Related Conditions & MeSH terms

• Knee Arthroplasty

Intervention

Device:
• Oxford Partial Knee
Oxford Partial Knee

Locations

Country	Name	City	State
Canada	Dartmouth General Hospital	Dartmouth

Sponsors (2)

Lead Sponsor	Collaborator
Zimmer Biomet	Dartmouth General Hospital

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	WOMAC, SF12, oxford Knee,KSCRS		3weeks, 3months,6months, yearly
Secondary	Length of Hospital Stay		Postop